In Brief: FDA 1996 budget optimism
This article was originally published in The Gray Sheet
FDA 1996 budget optimism: FDA device center has been instructed to include in its budget request for fiscal year 1996 (beginning Oct. 1) approximately $24 mil. in dedicated device user fees, according to agency staffers. The request would anticipate passage of device user fee legislation this year. However, the likelihood of device user fee passage is in doubt in this year's Republican-controlled Congress. The administration's FY 1995 budget request had included a similar amount in dedicated device user fees ("The Gray Sheet" Feb. 14, 1994, p. 1), but legislation to authorize collection of the fees died in the face of GOP opposition at the end of the 103rd Congress. The administration's FY 1996 budget is due to be submitted to Congress on Feb. 6...
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.